NCT00498537View on ClinicalTrials.gov

Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

June 30, 2006

Conditions
Diabetic Nephropathy
Interventions
DRUG

spironolactone

Trial Locations (1)

45428

VA Medical Center, Dayton, Dayton

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00498537 - Spironolactone for Reducing Proteinuria in Diabetic Nephropathy | Biotech Hunter | Biotech Hunter